SightfileU.S. market data from official filings

CORCEPT THERAPEUTICS INC (CORT)

Name: CORCEPT THERAPEUTICS INC (CORT) — Institutional ownership, SEC filings and insider activity
Creator: Sightfile
License: https://www.sec.gov/privacy#dissemination

Institutional ownership, SEC filings and insider activity

Sector: Healthcare & Pharma · SEC CIK 0001088856 · EDGAR filings · Updated 2026-07-17

CORCEPT THERAPEUTICS INC (CORT) has reported institutional ownership of 73.8%, with 348 institutional managers holding positions valued at $3.19B per the latest 13F reporting period.

Institutional ownership

73.8%

Institutional managers

348

Reported 13F value

$3.19B

Insider activity

288 trans.

−$90.1M net selling

Latest updates

2026-07-17 — Insider transaction reported (Form 4)
2026-07-17 — Insider transaction reported (Form 4)
2026-07-08 — Insider transaction reported (Form 4)
2026-07-08 — Insider transaction reported (Form 4)
2026-07-07 — Notice of proposed sale filed (Form 144)
2026-07-06 — Insider transaction reported (Form 4)

Institutional ownership overview

According to SEC 13F filings tracked by Sightfile, CORCEPT THERAPEUTICS INC has 348 institutional holders and institutional ownership of 73.8%.

Insider activity

Insiders reported 288 transactions (2 buys, 106 sells) across 12 reporting insiders, with a net reported value of −$90.1M.

Related companies

INTEGER HLDGS CORP (ITGR) · DYNE THERAPEUTICS INC (DYN) · STRUCTURE THERAPEUTICS INC (GPCR) · TARSUS PHARMACEUTICALS INC (TARS) · IDEAYA BIOSCIENCES INC (IDYA) · ARCUTIS BIOTHERAPEUTICS INC (ARQT)

See full history, cross-references and alerts on Sightfile

Sightfile provides information only — not investment advice, recommendations, or an assessment of any security. Data is derived from official public sources (SEC EDGAR and U.S. government agencies), may contain errors or delays, and should be verified against the source filing before relying on it.
Data sources: SEC EDGAR (filings, 13F, FTD), aggregated by Sightfile. Page updated 2026-07-17.